Market Insights & Analysis from Kramer Capital Research

Market Insights & Analysis from Kramer Capital Research

Netflix Earnings Were Great but I’m Not Buying

January 18, 2019

While everybody has an opinion on Netflix (NASDAQ:NFLX), the Jan. 17 earnings report that it released after the markets closed didn’t change a lot of minds. The bulls who had talked the stock up 55 percent since Christmas were relieved to see the paid audience grow by 8.84 million people, well above the 7.6 million […]

Seven Investments to Protect Your Portfolio from a Stock Market Crash

January 11, 2019

Wall Street is nervous. Earnings growth is deteriorating and stocks that were once household names are cratering. The yield curve has signaled that there will be a recession sometime in the next five years. Add a government shutdown that could trigger another U.S. credit downgrade, tension overseas and the highest interest rates in a decade, […]

Call Me When Apple Is Below $110

January 4, 2019

So, Apple (NASDAQ:AAPL) is having trouble selling iPhones in China. You’ve seen the headline and heard the chatter. Since Oct. 3, the stock has been down 40 percent from its all-time peak and $450 billion has been destroyed in the last 64 trading days. To a casual observer or an Apple hater, it looks like the […]

Subscribe to GameChangers

Hilary Kramer’s flagship newsletter, GameChangers identifies breakthrough, mega-trendsetter stocks ahead of the Wall Street herd, with a goal of delivering at least one double-digit gain every month.

Subscribe to Value Authority

Value Authority targets undervalued stocks with strong fundamentals: cash, earnings and valuation. These plays are especially effective because they offer a strong margin of safety to sustain any macro issues, such as higher rates or a slowing economy, while providing consistent double-digit returns in any market. Value Authority guarantees at least 10 double-digit wins per year.

Subscribe to High Octane Trader

Since High Octane Trader’s launch in 2011, readers have had the opportunity to bank over 600 winning options trades, and score wins at an 80% success rate over the last 12 months. High Octane Trader members expect quick-hitting gains and outsized payoffs, while trading several times per week.

Subscribe to Turbo Trader

The Turbo Trader portfolio focuses on bargain-priced ETFs, stocks, and commodities that are technically and fundamentally positioned to skyrocket over the coming one to three months.

Subscribe to Inner Circle

Membership in the Inner Circle features access to all four Hilary Kramer services:  GameChangers, Value Authority, High Octane Trader, and Turbo Trader.  As an Inner Circle member, you’ll also have access to exclusive stock picks, videos, live online chats, direct access to Hilary, and more.

Big Stock Wins

Stock NameDays HeldProfit
Sirius XM Radio344136.6%
Medical Action Industries51107.9%
Dot Hill Systems777.80%

Big Option Wins

Stock NameDays HeldProfit
Tempur Sealy International19243.4%
Ebay8157.8%
Google2154.3%
Regeneron Pharmaceuticals7131.4%

Testimonials

Investing has become fun, because most of your recommendations are winners.

— Gerhild T.

After 10 trades I am averaging 30%+!

— Bob

It is the best publication I have ever seen.  And I have seen probably 100 in my investment career which spans 56 years.

— Martin G.
Exclusive Report: 3 Biotech Breakthroughs To Bank On
X
Hilary Kramer
Legendary Wall St. trader Hilary Kramer

Where does the Smart Money look for the best biotech stocks? Small- and mid-cap biotechs. They're the ones with the ability to transform the world, and bring investors transformational profits. To get free access to Hilary Kramer's latest report, 3 Biotech Breakthroughs To Bank On, simply tell us where to send it in the box below.

Along with my FREE report, Hilary Kramer's 3 Biotech Breakthroughs to Bank On, please also send Hilary's free weekly e-letter, Trading Desk.
* We value your privacy. You will not be spammed, ever. Period.

Log In

Forgot Password

Search